Business Description

Description
Biomind Labs Inc is a biotech Research and Development company aimed at transforming biomedical sciences knowledge from natural psychotropic plants into novel pharmaceutical drugs and nanotech delivery systems for a variety of psychiatric and neurological conditions. Biomind is developing pharmaceutical sole and combined formulations of the main natural psychedelic molecules with the aim of identifying novel pharmaceutical compounds for treating a wide range of therapeutic indications.
Name Current Vs Industry Vs History
Cash-To-Debt 15.91
Equity-to-Asset -7.08
Debt-to-Equity -0.01
Debt-to-EBITDA -0.01
Piotroski F-Score 3/9
0
1
2
3
4
5
6
7
8
9
WACC vs ROIC
WACC
ROIC

Growth Rank

Name Current Vs Industry Vs History

Momentum Rank

Name Current Vs Industry Vs History
5-Day RSI 33.2
9-Day RSI 45.75
14-Day RSI 52.78
6-1 Month Momentum % 50
12-1 Month Momentum % -10.71

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 0.1
Quick Ratio 0.1
Cash Ratio 0.1

Dividend & Buy Back

Name Current Vs Industry Vs History
Shareholder Yield % 0.11
Name Current Vs Industry Vs History
ROA % -769.35
ROIC % -446.89
ROC (Joel Greenblatt) % -3830.74

GF Value Rank

Name Current Vs Industry Vs History
EV-to-EBIT -14.15
EV-to-EBITDA -14.42
EV-to-FCF -23.14
Earnings Yield (Greenblatt) % -7.07
FCF Yield % -4.29

Financials

NEOE:BMND's 30-Y Financials
Income Statement Breakdown FY
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

Biomind Labs Inc Executives

Details

GF Value

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil C$)
EPS (TTM) (C$) -0.045
Beta 0
Volatility % 218.83
14-Day RSI 52.78
14-Day ATR (C$) 0.00218
20-Day SMA (C$) 0.375
12-1 Month Momentum % -10.71
52-Week Range (C$) 0.025 - 0.5
Shares Outstanding (Mil) 74.76

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 3
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Biomind Labs Inc Filings

Filing Date Document Date Form
No Filing Data

Biomind Labs Inc Stock Events

Financials Calendars
Event Date Price(C$)
No Event Data

Biomind Labs Inc Frequently Asked Questions

What is Biomind Labs Inc(NEOE:BMND)'s stock price today?
The current price of NEOE:BMND is C$0.38. The 52 week high of NEOE:BMND is C$0.50 and 52 week low is C$0.03.
When is next earnings date of Biomind Labs Inc(NEOE:BMND)?
The next earnings date of Biomind Labs Inc(NEOE:BMND) is .
Does Biomind Labs Inc(NEOE:BMND) pay dividends? If so, how much?
Biomind Labs Inc(NEOE:BMND) does not pay dividend.

Press Release

Subject Date
No Press Release